Related Experiment Video

Updated: Jul 19, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

Why cardioverter-defibrillator implantation might not be the best idea for your elderly patient

Michael J Yarnoz1, Anne B Curtis

  • 1Division of Cardiovascular Disease, University of South Florida, Tampa, FL 33612, USA.

The American Journal of Geriatric Cardiology
|November 7, 2006
PubMed

Insights

Implantable cardioverter-defibrillators (ICDs) improve survival but may not be suitable for elderly patients due to their health conditions and potential complications. Further review suggests caution in widespread ICD use for this demographic.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Medical Device Technology

Background:

  • Implantable cardioverter-defibrillators (ICDs) are established treatments for preventing sudden cardiac death.
  • Recent clinical trials show survival benefits of ICDs across diverse patient groups.
  • Elderly patients present unique challenges including limited life expectancy and multiple comorbidities.

Purpose of the Study:

  • To evaluate the appropriateness of mainstream implantable cardioverter-defibrillator (ICD) use in elderly patients.
  • To analyze the scientific literature regarding ICD implantation outcomes in the geriatric population.
  • To discuss potential limitations and contraindications for ICDs in older adults.

Main Methods:

  • Systematic review of existing scientific literature on ICDs in elderly patients.
  • Analysis of clinical trial data concerning survival benefits and complications.
  • Discussion of factors influencing ICD efficacy in patients with advanced age and comorbidities.

Main Results:

  • Elderly patients often have comorbidities that may limit the survival benefits observed in general clinical trials.
  • Complications associated with ICD implantation can be more significant in older individuals.
  • The overall risk-benefit profile for ICDs in the elderly may differ substantially from younger populations.

Conclusions:

  • Mainstream adoption of ICDs in the elderly population may not yield comparable results to those seen in clinical trials.
  • Careful consideration of individual patient factors, including comorbidities and life expectancy, is crucial before ICD implantation in older adults.
  • The current evidence suggests that widespread ICD use in the elderly may not be advisable without further specific research.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...